PE-22-28 Dosage Guide
Complete guide to PE-22-28 dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
500 mcg – 2 mg
Frequency
Once per day
Route
subcutaneous
Cycle Length
1–2 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Research protocols vary.
Intranasal dosing has been studied at various concentrations.
Optimal human dosing not established.
Administration Method
Intranasal administration preferred for CNS delivery. Research compound with limited human use data.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.500 ml
Syringe units: 50.0 units — fits 0.5 ml syringe
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with PE-22-28 defaults. Adjust values as needed.
Side Effects to Monitor
Very limited human data. Primarily studied in animal models for safety and efficacy.
Safety Considerations & Risks
Highly experimental. Most data from animal studies. Long-term effects completely unknown.